Categories: Current Updates

Covaxin will get approved for children till September: AIIMS Director

The Director of All India Institute of Medical Sciences (AIIMS), Dr. Randeep Guleria revealed that the Covid-19 vaccine, Covaxin of Bharat Biotech International Limited, will supposedly be approved for children till September.

Dr. Guleria told India Today, “After the completion of the second and third phase of trials of Covaxin for children, the trial data would be made available by September and the vaccine itself is likely to be approved in the same month.”

He also added that another vaccine developed by Pfizer-BioNtech on its approval will be another alternative vaccine for children to be inoculated with.

Related Post

According to the predictions of various experts that the third wave of Covid-19 will affect the children severely, the clinical trials of Covaxin are underway on children from 2-17 years of age at Delhi and Patna. Earlier, on May 12, the Drugs Controller General of India (DCGI) granted approval to Bharat Biotech for beginning phase 2 and phase 3 trials for children.

Although, Dr. Guleria disagreed with the prediction that the children will be impacted in the third wave, adding there is “no reason to believe this theory.” This synchronizes with the statement given by AIIMS-World Health Organization (WHO) report which revealed the third wave “may not hit children disproportionately.”

He further urged the policymakers to deliberate on resuming the schools, though he also said it should be assured that educational institutes do not turn into “super spreaders”. He recommended that this could be achieved by opening schools on alternative days for the containment zones, and assist the children in adhering to Covid-19 appropriate behavior.

Team Newsnap
Leave a Comment

Recent Posts

Statewide Transport Workers’ Strike from Dec 31: Disruption in Bus Services Likely

Bengaluru: Transport department employees in Karnataka have called for a statewide strike starting December 31,… Read More

12 hours ago

Mandya Kannada Sahitya Sammelana: Traffic Diversion on Bengaluru-Mysuru Expressway

New Traffic Rules on Bengaluru-Mysuru ExpresswayIn light of the Kannada Sahitya Sammelana taking place in… Read More

13 hours ago

Ravichandran Ashwin Announces Sudden Retirement from International Cricket

Brisbane, Gabba Stadium: The third match of the five-match Test series between India and Australia… Read More

1 day ago

Free Cancer Vaccine Distribution in Russia from 2025: A Remarkable Medical Breakthrough

The development was revealed by the Radiological Medical Research Center's General Director during a Russian… Read More

2 days ago

Train Services Delayed Between Bengaluru-Mysuru: Introduction of New Train Numbers

Bengaluru: The South Western Railway (SWR) has announced that train services between Bengaluru and Mysuru… Read More

2 days ago

One Nation, One Election Bill Presented in Lok Sabha: Strong Opposition from Parties

New Delhi: The "One Nation, One Election" bill, which aims to allow simultaneous Lok Sabha… Read More

2 days ago